Pancreas divisum is a condition that affects the pancreas, an organ located in the abdomen. It occurs when the pancreas does not develop normally during fetal development. As a result, the pancreas is divided into two parts, rather than one. This condition is relatively rare, affecting only about 5-10% of the population. While it is not life-threatening, it can cause serious complications, such as pancreatitis, which can lead to abdominal pain, nausea, and vomiting. In some cases, it can also lead to chronic pancreatitis, which can cause further complications, including diabetes and malabsorption. Because of the potential complications associated with pancreas divisum, it is important to understand the condition and explore new treatment options. In this article, we will explore the causes, symptoms, and diagnosis of pancreas divisum, as well as the potential treatments available.
Pancreas divisum is a congenital condition that occurs when the pancreas does not develop normally during fetal development. Normally, the pancreas is divided into two parts, the head and the tail. In pancreas divisum, the two parts do not join together, resulting in two separate sections of the pancreas. This condition is relatively rare, affecting only about 5-10% of the population.
The exact cause of pancreas divisum is not known. It is thought to be caused by a failure of the ducts that connect the two parts of the pancreas to join together during fetal development. It is believed to be an inherited condition, although it can also occur spontaneously in some cases.
Most people with pancreas divisum do not experience any symptoms. However, some people may experience abdominal pain, nausea, and vomiting. In some cases, it can also lead to chronic pancreatitis, which can cause further complications, including diabetes and malabsorption.
Pancreas divisum is typically diagnosed with imaging tests, such as an abdominal ultrasound or a CT scan. These tests can help to identify the presence of two separate sections of the pancreas. In some cases, a special dye may be injected into the pancreas to help identify the two sections.
The treatment for pancreas divisum depends on the severity of the condition and the symptoms that are present. In most cases, no treatment is necessary. However, if the condition is causing symptoms, such as abdominal pain, nausea, and vomiting, then treatment may be necessary. The most common treatment for pancreas divisum is endoscopic retrograde cholangiopancreatography (ERCP). During this procedure, a small tube is inserted into the pancreas and a special dye is injected. This helps to identify the two separate sections of the pancreas. Once the sections are identified, a stent can be placed to help the two sections join together. In some cases, surgery may be necessary to correct the condition. During surgery, the two sections of the pancreas are joined together. This helps to reduce the risk of complications, such as pancreatitis.
In recent years, there has been an increase in research into new treatments for pancreas divisum. One of the most promising treatments is a procedure called sphincterotomy. During this procedure, a small incision is made in the sphincter muscle that separates the two sections of the pancreas. This helps to allow the two sections to join together. Another potential treatment is a procedure called duodenal switch. During this procedure, part of the small intestine is removed and used to connect the two sections of the pancreas. This helps to reduce the risk of complications, such as pancreatitis. Finally, there is also research into the use of stem cells to treat pancreas divisum. Stem cells are cells that can develop into any type of cell in the body. Researchers are exploring the potential of using stem cells to help the two sections of the pancreas join together.
1.
Study confirms link between breast density, higher breast cancer risk
2.
FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor
3.
Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma
4.
Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants
5.
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
1.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
2.
Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology
3.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
4.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
5.
Oncolytic Viruses in Breast Cancer: Unlocking Synergy with Novel Combination Therapies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Cancer- Q&A Session to Close the Gap
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation